Michael Auerbach

7.6k total citations · 2 hit papers
110 papers, 4.8k citations indexed

About

Michael Auerbach is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Auerbach has authored 110 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 70 papers in Genetics and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Auerbach's work include Iron Metabolism and Disorders (71 papers), Hemoglobinopathies and Related Disorders (64 papers) and Erythropoietin and Anemia Treatment (58 papers). Michael Auerbach is often cited by papers focused on Iron Metabolism and Disorders (71 papers), Hemoglobinopathies and Related Disorders (64 papers) and Erythropoietin and Anemia Treatment (58 papers). Michael Auerbach collaborates with scholars based in United States, United Kingdom and Spain. Michael Auerbach's co-authors include Harold S. Ballard, Iain C. Macdougall, Huzefa Bahrain, John W. Adamson, Aryeh Shander, David H. Henry, Naomi V. Dahl, John A. Glaspy, Thomas G. DeLoughery and Richard J. Derman and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

Michael Auerbach

106 papers receiving 4.6k citations

Hit Papers

International consensus statement on the peri‐operative m... 2016 2026 2019 2022 2016 2025 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Auerbach United States 38 3.1k 1.9k 860 443 345 110 4.8k
Khaled M. Musallam Lebanon 42 4.2k 1.3× 4.2k 2.2× 565 0.7× 336 0.8× 714 2.1× 173 6.7k
Thomas G. DeLoughery United States 33 1.3k 0.4× 671 0.4× 306 0.4× 264 0.6× 767 2.2× 179 4.0k
Joseph J. Shatzel United States 28 829 0.3× 683 0.4× 131 0.2× 299 0.7× 409 1.2× 156 2.7k
Antonio Coppola Italy 41 2.5k 0.8× 599 0.3× 83 0.1× 258 0.6× 632 1.8× 206 4.4k
M Brozović United Kingdom 30 1.7k 0.5× 1.2k 0.6× 121 0.1× 621 1.4× 623 1.8× 74 4.4k
Mehran Karimi Iran 37 3.4k 1.1× 3.1k 1.6× 42 0.0× 385 0.9× 236 0.7× 364 5.7k
Daniel W. Coyne United States 39 1.8k 0.6× 1.1k 0.6× 81 0.1× 296 0.7× 484 1.4× 122 5.1k
Dimitrios Farmakis Greece 46 1.7k 0.5× 1.9k 1.0× 42 0.0× 428 1.0× 936 2.7× 245 7.2k
Riitta Lassila Finland 36 1.7k 0.5× 312 0.2× 76 0.1× 474 1.1× 1.0k 3.0× 213 4.7k
Ian J. Welsby United States 34 693 0.2× 164 0.1× 690 0.8× 299 0.7× 1.6k 4.7× 141 3.9k

Countries citing papers authored by Michael Auerbach

Since Specialization
Citations

This map shows the geographic impact of Michael Auerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Auerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Auerbach more than expected).

Fields of papers citing papers by Michael Auerbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Auerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Auerbach. The network helps show where Michael Auerbach may publish in the future.

Co-authorship network of co-authors of Michael Auerbach

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Auerbach. A scholar is included among the top collaborators of Michael Auerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Auerbach. Michael Auerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Auerbach, Michael, et al.. (2023). Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials. Current Oncology. 30(9). 7836–7851. 5 indexed citations
5.
Auerbach, Michael. (2023). Optimizing diagnosis and treatment of iron deficiency and iron deficiency anemia in women and girls of reproductive age: Clinical opinion. International Journal of Gynecology & Obstetrics. 162(S2). 68–77. 15 indexed citations
6.
Auerbach, Michael, Maureen M. Achebe, Lars L. Thomsen, & Richard J. Derman. (2022). Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Obesity Surgery. 32(3). 810–818. 7 indexed citations
7.
Auerbach, Michael, Anat Gafter‐Gvili, & Iain C. Macdougall. (2020). Intravenous iron: a framework for changing the management of iron deficiency. The Lancet Haematology. 7(4). e342–e350. 58 indexed citations
8.
Auerbach, Michael, et al.. (2019). Prevalence of iron deficiency in first trimester, nonanemic pregnant women. The Journal of Maternal-Fetal & Neonatal Medicine. 34(6). 1002–1005. 68 indexed citations
9.
Juul, Sandra E., Richard J. Derman, & Michael Auerbach. (2019). Perinatal Iron Deficiency: Implications for Mothers and Infants. Neonatology. 115(3). 269–274. 68 indexed citations
10.
Allen, Richard P., Daniel L. Picchietti, Michael Auerbach, et al.. (2017). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Medicine. 41. 27–44. 193 indexed citations
11.
Auerbach, Michael, et al.. (2017). Results of the First American Prospective Study of Intravenous Iron in Oral Iron-Intolerant Iron-Deficient Gravidas. The American Journal of Medicine. 130(12). 1402–1407. 24 indexed citations
12.
Mehmood, Tahir, Michael Auerbach, Christopher J. Earley, & Richard P. Allen. (2014). Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis–Ekbom disease). Sleep Medicine. 15(12). 1473–1476. 41 indexed citations
13.
Shander, Aryeh, Lawrence T. Goodnough, Mazyar Javidroozi, et al.. (2014). Iron Deficiency Anemia—Bridging the Knowledge and Practice Gap. Transfusion Medicine Reviews. 28(3). 156–166. 78 indexed citations
14.
Bircher, Andreas J. & Michael Auerbach. (2014). Hypersensitivity from Intravenous Iron Products. Immunology and Allergy Clinics of North America. 34(3). 707–723. 65 indexed citations
15.
Yared, Jean A., Amy Kimball, Maria R. Baer, Huzefa Bahrain, & Michael Auerbach. (2013). Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 13(3). 253–257. 7 indexed citations
16.
Auerbach, Michael, Peter T. Silberstein, R. Timothy Webb, et al.. (2010). Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia. American Journal of Hematology. 85(9). 655–663. 71 indexed citations
17.
Auerbach, Michael, et al.. (2008). Intravenous iron: From anathema to standard of care. American Journal of Hematology. 83(7). 580–588. 82 indexed citations
18.
Auerbach, Michael, Harold S. Ballard, & John A. Glaspy. (2007). Clinical update: intravenous iron for anaemia. The Lancet. 369(9572). 1502–1504. 149 indexed citations
19.
Cavill, Ivor, Michael Auerbach, George R. Bailie, et al.. (2006). Iron and the anaemia of chronic disease: a review and strategic recommendations. Current Medical Research and Opinion. 22(4). 731–737. 61 indexed citations
20.
Auerbach, Michael, et al.. (1998). Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: A double blind randomized trial. Journal of Laboratory and Clinical Medicine. 131(3). 257–260. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026